Cited by 4,958Liver physiology and pathologyLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation

The DOI matches its Crossref record; 136 of the 138 references it cites were found in a registry or an index, and 2 are not checked yet.

Liver fibrosis

Open access

Bataller, Ramón, Brenner, David A.·2005·Journal of Clinical Investigation

DOI 10.1172/jci24282

Open this paper in CoChat — free account Open PDF

Abstract

Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. Advanced liver fibrosis results in cirrhosis, liver failure, and portal hypertension and often requires liver transplantation. Our knowledge of the cellular and molecular mechanisms of liver fibrosis has greatly advanced. Activated hepatic stellate cells, portal fibroblasts, and myofibroblasts of bone marrow origin have been identified as major collagen-producing cells in the injured liver. These cells are activated by fibrogenic cytokines such as TGF-beta1, angiotensin II, and leptin. Reversibility of advanced liver fibrosis in patients has been recently documented, which has stimulated researchers to develop antifibrotic drugs. Emerging antifibrotic therapies are aimed at inhibiting the accumulation of fibrogenic cells and/or preventing the deposition of extracellular matrix proteins. Although many therapeutic interventions are effective in experimental models of liver fibrosis, their efficacy and safety in humans is unknown. This review summarizes recent progress in the study of the pathogenesis and diagnosis of liver fibrosis and discusses current antifibrotic strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci24282

Cites

136 of 138 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,414
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Nonalcoholic Steatohepatitis
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
J. Submicrosc. Cytol. Pathol.
Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,171
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
Regev, A., Berho, M. E., Jeffers, L. J., Milikowski, C., Molina, E. G., Pyrsopoulos, N., Feng, Z.-Z., Reddy, K. R., & Schiff, E. R. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06038.x · Cited by 2,078
Hepatogastroenterology
Xu, D., He, X., Chang, Y., Sun, S., Xu, C., & Lin, J. (2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780

Flagged first, then by citations

Show all 134 references

Research works printed but not linked: 9

Soyer, 1976, Surgery., 79, 601
Otto, 1980, Adv. Exp. Med. Biol., 132, 509
Wasser, 1999, Ann. Acad. Med. Singapore., 28, 109
Brunt, 2004, Semin. Liver Dis., 24, 3
Phillips, 2004, J. Clin. Invest., 114, 438, 10.1172/jci200420997 · DOI
Kmiec, 2001, Adv. Anat. Embryol. Cell Biol., 161, III–XIII, 1–151
Thurman, 1998, Am. J. Physiol., 275, G605
Wei, 2000, World J. Gastroenterol., 6, 540
Tuncer, 2003, Exp. Toxicol. Pathol., 55, 159

Sorted by citations

Items 901–1,000 of 1,040

Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro
Kanabekova, P., Kadyrova, A., & Kulsharova, G. (2022) · Micromachines · doi:10.3390/mi13030428 · Cited by 73
Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells
Wirz, W., Antoine, M., Tag, C. G., Gressner, A. M., Korff, T., Hellerbrand, C., & Kiefer, P. (2008) · Differentiation · doi:10.1111/j.1432-0436.2007.00260.x · Cited by 73
ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells
Rovida, E., Navari, N., Caligiuri, A., Sbarba, P. D., & Marra, F. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.010 · Cited by 73
Endocannabinoids and Liver Disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis
Siegmund, S., & Schwabe, R. F. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00456.2007 · Cited by 73
Assessment of liver steatosis and fibrosis in rats using integrated coherent anti-Stokes Raman scattering and multiphoton imaging technique
Lin, J., Lu, F., Zheng, W., Huang, Z., Xu, S., Tai, D., & Yu, H. (2011) · Journal of Biomedical Optics · doi:10.1117/1.3655353 · Cited by 73
Cell Signals Influencing Hepatic Fibrosis
Cong, M., Iwaisako, K., Jiang, C., & Kisseleva, T. (2012) · International Journal of Hepatology · doi:10.1155/2012/158547 · Cited by 74
Broad-Spectrum Matrix Metalloproteinase Inhibition Curbs Inflammation and Liver Injury but Aggravates Experimental Liver Fibrosis in Mice
de Meijer, V. E., Sverdlov, D., Popov, Y. V., Le, H. D., Meisel, J. A., Nosé, V., Schuppan, D., & Puder, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011256 · Cited by 73
Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt
Han, C. Y., Koo, J. H., Kim, S. H., Gardenghi, S., Rivella, S., Strnad, P., Hwang, S. J., & Kim, S. G. (2016) · Nature Communications · doi:10.1038/ncomms13817 · Cited by 73
Baicalin inhibits PDGF-BB-induced hepatic stellate cell proliferation, apoptosis, invasion, migration and activation via the miR-3595/ACSL4 axis
Wu, X., Zhi, F., Lun, W., Deng, Q., & Zhang, W. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3427 · Cited by 73
Deficient Natural Killer Cell NKp30‐Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma
Mantovani, S., Oliviero, B., Lombardi, A., Varchetta, S., Mele, D., Sangiovanni, A., Rossi, G. E., Donadon, M., Torzilli, G., Soldani, C., et al. (2018) · Hepatology · doi:10.1002/hep.30235 · Cited by 73
The STAT3 inhibitor S3I-201 suppresses fibrogenesis and angiogenesis in liver fibrosis
Wang, Z., Li, J., Xiao, W., Long, J., & Zhang, H. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0127-3 · Cited by 73
Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis
Pandey, S. P., Bender, M. J., McPherson, A. C., Phelps, C. M., Sanchez, L. M., Rana, M., Hedden, L., Sangani, K. A., Chen, L., Shapira, J. H., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.05.006 · Cited by 72
Sphingosine‐1‐phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy
Kawai, H., Osawa, Y., Matsuda, M., Tsunoda, T., Yanagida, K., Hishikawa, D., Okawara, M., Sakamoto, Y., Shimagaki, T., Tsutsui, Y., et al. (2022) · Hepatology · doi:10.1002/hep.32256 · Cited by 72
Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective
Gerarduzzi, C., & Battista, J. A. D. (2016) · Inflammation Research · doi:10.1007/s00011-016-1019-x · Cited by 72
Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases
Li, X., Ge, J., Zheng, Q., Zhang, J., Sun, R., & Liu, R. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153180 · Cited by 72
Genome-wide analysis of DNA methylation and gene expression patterns in purified, uncultured human liver cells and activated hepatic stellate cells
Taghdouini, A. E., Sørensen, A. L., Reiner, A. H., Coll, M., Verhulst, S., Mannaerts, I., Øie, C. I., Smedsrød, B. H., Najimi, M., Sokal, E. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4925 · Cited by 72
Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function
Yoneyama, T., Fukukura, Y., Kamimura, K., Takumi, K., Umanodan, A., Ueno, S., & Nakajo, M. (2013) · European Radiology · doi:10.1007/s00330-013-3086-5 · Cited by 72
Antifibrotic activity of Taraxacum officinale root in carbon tetrachloride-induced liver damage in mice
Domitrović, R., Jakovac, H., Romić, Ž., Rahelić, D., & Tadić, Ž. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.05.046 · Cited by 72
Retinyl ester hydrolases and their roles in vitamin A homeostasis
Schreiber, R., Taschler, U., Preiss-Landl, K., Wongsiriroj, N., Zimmermann, R., & Lass, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.05.001 · Cited by 72
The role of the renin–angiotensin system in liver fibrosis
Munshi, M., Uddin, M. N., & Glaser, S. S. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010375 · Cited by 72
Extracellular matrix rigidity controls podosome induction in microvascular endothelial cells
Juin, A., Planus, E., Guillemot, F., Horakova, P., Albigès‐Rizo, C., Genot, E. M., Rosenbaum, J., Moreau, V., & Saltel, F. (2012) · Biology of the Cell · doi:10.1111/boc.201200037 · Cited by 72
Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells
Liu, H., Wei, W., Sun, W., & Li, X. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.01.035 · Cited by 72
Targeting the insulin-like growth factor pathway in hepatocellular carcinoma
Enguita‐Germán, M. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i10.716 · Cited by 72
Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis
Ali, G., Mohsin, S., Khan, M., Nasir, G. A., Shams, S., Khan, S. N., & Riazuddin, S. A. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-75 · Cited by 72
A Fibronectin-Independent Mechanism of Collagen Fibrillogenesis in Adult Liver Remodeling
Moriya, K., Bae, E., Honda, K., Sakai, K., Sakaguchi, T., Tsujimoto, I., Kamisoyama, H., Keene, D. R., Sasaki, T., & Sakai, T. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.005 · Cited by 71
The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis.
Roy, S., Benz, F., Luedde, T., & Roderburg, C. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2015.01.05 · Cited by 72
Long noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins
Zhou, C., York, S. R., Chen, J. Y., Pondick, J. V., Motola, D., Chung, R. T., & Mullen, A. C. (2016) · Genome Medicine · doi:10.1186/s13073-016-0285-0 · Cited by 72
Epigenetic Mechanisms in Hepatic Stellate Cell Activation During Liver Fibrosis and Carcinogenesis
Bárcena‐Varela, M., Colyn, L., & Fernández‐Barrena, M. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102507 · Cited by 74
Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and acute liver injury in vivo
Kurniawan, D. W., Booijink, R. S., Pater, L. V., Wols, I., Vrynas, A. V., Storm, G., Prakash, J., & Bansal, R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.041 · Cited by 72
ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride–induced hepatic fibrosis in mice
Kesteloot, F., Desmoulière, A., Leclercq, I. A., Thiry, M., Arrese, J. E., Prockop, D. J., Lapiere, C. M., Nusgens, B., & Colige, A. (2007) · Hepatology · doi:10.1002/hep.21868 · Cited by 72
Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis
Kwak, K.-A., Cho, H., Yang, J.-Y., & Park, Y. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/4197857 · Cited by 71
Oral Dysbiosis in Pancreatic Cancer and Liver Cirrhosis: A Review of the Literature
Mohammed, H., Varoni, E. M., Cochis, A., Cordaro, M., Gallenzi, P., Patini, R., Staderini, E., Lajolo, C., Rimondini, L., & Rocchetti, V. (2018) · Biomedicines · doi:10.3390/biomedicines6040115 · Cited by 71
sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p
Kim, J., Lee, C., Shin, Y., Wang, S., Han, J., Kim, M., Kim, J. M., Shin, S., Lee, B., Kim, T., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.025 · Cited by 71
Naringenin: A Promising Therapeutic Agent against Organ Fibrosis
Du, Y., Ma, J., Fan, Y., Wang, X., Zheng, S., Feng, J., Li, J., Fan, Z., Li, G., & Ye, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1210675 · Cited by 71
Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies
Ballerini, P., Contursi, A., Bruno, A., Mucci, M., Tacconelli, S., & Patrignani, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.838079 · Cited by 71
Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice
Liu, Q., Ying, Y.-M., Zhou, J., Zhang, W., Liu, Z.-X., Jia, B., Gu, H., Zhao, C.-Y., Guan, X., Deng, K., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02906-z · Cited by 71
SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation
Yan, L., Zhang, T., Wang, K., Chen, Z., Yang, Y., Shan, B., Sun, Q., Zhang, M., Zhang, Y., Zhong, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34993-0 · Cited by 71
The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: Persistent p27Kip1 induction by interfering with PI3K/Akt/FOXO3a signaling pathway
Li, A., Wang, J., Wu, M., Zhang, X., & Zhang, H. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.040 · Cited by 71
New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system
Berasain, C., Castillo, J., Prìeto, J., & Avila, M. A. (2007) · Liver International · doi:10.1111/j.1478-3231.2006.01424.x · Cited by 71
Mitochondrial Oxidative Stress due to Complex I Dysfunction Promotes Fibroblast Activation and Melanoma Cell Invasiveness
Taddei, M. L., Giannoni, E., Raugei, G., Scacco, S., Sardanelli, A. M., Papa, S., & Chiarugi, P. (2012) · Journal of Signal Transduction · doi:10.1155/2012/684592 · Cited by 71
Orientation fields of nonlinear biological fibrils by second harmonic generation microscopy
Odin, C., Grand, Y. L., Renault, A., Gailhouste, L., & Baffet, G. (2007) · Journal of Microscopy · doi:10.1111/j.1365-2818.2007.01868.x · Cited by 71
Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma
Aquino, J. B., Bolontrade, M. F., García, M. G., Podhajcer, O. L., & Mazzolini, G. D. (2010) · Gene Therapy · doi:10.1038/gt.2010.10 · Cited by 71
Analysis of Disease-Associated Protein Expression Using Quantitative Proteomics—Fibulin-5 Is Expressed in Association with Hepatic Fibrosis
Bracht, T., Schweinsberg, V., Trippler, M., Kohl, M., Ahrens, M., Padden, J., Naboulsi, W., Barkovits, K., Megger, D. A., Eisenacher, M., et al. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00053 · Cited by 71
NAFLD and HBV interplay - related mechanisms underlying liver disease progression
Tourkochristou, E., Assimakopoulos, S. F., Thomopoulos, K., Marangos, M., & Triantos, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.965548 · Cited by 70
Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives
Somnay, K., Wadgaonkar, P., Sridhar, N., Roshni, P., Rao, N., & Wadgaonkar, R. (2024) · Biomedicines · doi:10.3390/biomedicines12102229 · Cited by 70
Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12
Arab, J. P., Cabrera, D., Sehrawat, T. S., Jalan‐Sakrikar, N., Verma, V. K., Simonetto, D. A., Cao, S., Yaqoob, U., León, J., Freire, M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.005 · Cited by 70
Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
Qu, W., Ma, T., Cai, J., Zhang, X., Zhang, P., She, Z., Wan, F., & Li, H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.761538 · Cited by 71
Stiffness is associated with hepatic stellate cell heterogeneity during liver fibrosis
Kostallari, E., Wei, B., Sicard, D., Li, J., Cooper, S. A., Gao, J., Dehankar, M. K., Li, Y., Cao, S., Yin, M., et al. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00254.2021 · Cited by 70
Purinergic signaling in scarring
Ferrari, D., Gambari, R., Idzko, M., Müller, T., Albanesi, C., Pastore, S., Manna, G. L., Robson, S. C., & Cronstein, B. N. (2015) · The FASEB Journal · doi:10.1096/fj.15-274563 · Cited by 70
Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats
Huang, H., Wang, S.-S., Hsin, I., Chang, C.-C., Lee, F., Lin, H., Chuang, C., Lee, J.-Y., Hsieh, H., & Lee, S. (2012) · Hepatology · doi:10.1002/hep.25625 · Cited by 70
Protection against Hepatocyte Mitochondrial Dysfunction Delays Fibrosis Progression in Mice
Mitchell, C., Robin, M., Mayeuf-Louchart, A., Mahrouf‐Yorgov, M., Mansouri, A., Hamard, M., Couton, D., Fromenty, B., & Gilgenkrantz, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090332 · Cited by 70
Stratification of Patients With Liver Fibrosis Using Dual-Energy CT
Lamb, P., Sahani, D. V., Fuentes, J. M., Patiño, M., Ghosh, A., & Mendonça, P. R. S. (2014) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2014.2353044 · Cited by 70
The use of low molecular weight heparin–pluronic nanogels to impede liver fibrosis by inhibition the TGF-β/Smad signaling pathway
Lee, J., Lee, H., Joung, Y. K., Jung, K. H., Choi, J.-H., Lee, D., Park, K. D., & Hong, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.023 · Cited by 70
Effects of Taurine Supplementation on Hepatic Markers of Inflammation and Lipid Metabolism in Mothers and Offspring in the Setting of Maternal Obesity
Li, M., Reynolds, C. M., Sloboda, D. M., Gray, C. L., & Vickers, M. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076961 · Cited by 70
Texture analysis of liver fibrosis microscopic images: a study on the effect of biomarkers
Amin, A., & Mahmoud‐Ghoneim, D. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmq129 · Cited by 70
Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness
Stasi, C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i4.1711 · Cited by 70
Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology
Rohrbach, T. D., Maceyka, M. W., & Spiegel, S. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1337706 · Cited by 70
Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury
Konishi, T., Schuster, R. M., & Lentsch, A. B. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00153.2017 · Cited by 70
CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78)
Aran, G., Sanjurjo, L., Bárcena, C., Simon‐Coma, M., Téllez, É., Vázquez‐Vitali, M., Garrido‐Pontnou, M., Guerra, L., Díaz, E., Ojanguren, I., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700941rr · Cited by 70
Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal
Lee, E. H., Park, K., Kim, K.-Y., Lee, J., Jang, E. J., Ku, S., Kim, S. C., Suk, H. Y., Park, J. Y., Baek, S. Y., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.12.003 · Cited by 70
Progranulin attenuates liver fibrosis by downregulating the inflammatory response
Yoo, W., Lee, J., Noh, K. H., Lee, S., Jung, D., Kabir, M. H., Park, D., Lee, C., Kwon, K., Kim, J.-S., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1994-2 · Cited by 70
Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs
Hadjicharalambous, M. R., & Lindsay, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020524 · Cited by 70
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection
Wasmuth, H. E., Zaldivar, M. M., Berres, M., Werth, A., Scholten, D., Hillebrandt, S., Tacke, F., Schmitz, P., Dahl, E., Wiederholt, T., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.008 · Cited by 70
Retinoic Acid Receptor‐β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin‐Driven Activation and Durotaxis in Hepatic Stellate Cells
Cortes, E., Lachowski, D., Rice, A., Chronopoulos, A., Robinson, B., Thorpe, S., Lee, D. A., Possamai, L. A., Wang, H., Pinato, D. J., et al. (2019) · Hepatology · doi:10.1002/hep.30193 · Cited by 64
Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis
Wu, Y., Cao, Y., Xu, K., Zhu, Y., Qiao, Y., Wu, Y., Chen, J., Li, C., Zeng, R., & Ge, G. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03443-y · Cited by 69
Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms
Wang, C., Ma, C., Gong, L., Dai, S., & Li, Y. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174604 · Cited by 69
Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation
Guo, R., Jia, X., Ding, Z., Wang, G., Jiang, M., Li, B., Chen, S., Xia, B., Zhang, Q., Liu, J., et al. (2022) · Theranostics · doi:10.7150/thno.71400 · Cited by 69
Hepatocyte Ninjurin2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R/EGR1/PDGF-BB signaling pathway
Wang, Y., Wang, P., Yu, Y., Huang, E., Yao, Y., Guo, D., Peng, H., Tian, B., Zheng, Q., Jia, M., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155380 · Cited by 69
Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease
Bukke, V. N., Moola, A., Serviddio, G., Vendemiale, G., & Bellanti, F. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i48.6909 · Cited by 69
microRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor γ
Li, X., CHEN, Y., Wu, S., He, J., Lou, L., Ye, W., & WANG, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2846 · Cited by 69
Toll-like receptors as therapeutic targets in gastrointestinal diseases
Pimentel‐Nunes, P., Soares, J., Roncon‐Albuquerque, R., Dinis-Ribeiro, M. J., & Leite-Moreira, A. F. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003642027 · Cited by 70
Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects
Onoue, S., Nakamura, T., Uchida, A., Ogawa, K., Yuminoki, K., Hashimoto, N., Hiza, A., Tsukaguchi, Y., Asakawa, T., Kan, T., et al. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.014 · Cited by 69
CD38-mediated Ca2+ Signaling Contributes to Angiotensin II-induced Activation of Hepatic Stellate Cells
Kim, S.-Y., Cho, B. H., & Kim, U. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.076216 · Cited by 69
Role of β3‐adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis†
Trebicka, J., Hennenberg, M., Pröbsting, A. S., Laleman, W., Klein, S., Granzow, M., Nevens, F., Zaagsma, J., Heller, J., & Sauerbruch, T. (2009) · Hepatology · doi:10.1002/hep.23222 · Cited by 69
Melittin attenuates liver injury in thioacetamide-treated mice through modulating inflammation and fibrogenesis
Park, J., Kum, Y., Lee, T.-I., Kim, S.-J., Lee, W., Kim, B., Kim, H.-S., Kim, K. H., & Park, K. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011127 · Cited by 69
Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs
Westra, I. M., Oosterhuis, D., Groothuis, G. M. M., & Olinga, P. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.11.017 · Cited by 69
Regulatory Effect of Extracellular Signal-Regulated Kinases (ERK) on Type I Collagen Synthesis in Human Dermal Fibroblasts Stimulated by IL-4 and IL-13
Bhogal, R. K., & Bona, C. A. (2008) · International Reviews of Immunology · doi:10.1080/08830180802430974 · Cited by 69
Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice
Lei, X., Fu, W., Kim‐Kaneyama, J., Omoto, T., Miyazaki, T., Li, B., & Miyazaki, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.026 · Cited by 69
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis
Klein, S., Rick, J., Lehmann, J., Schierwagen, R., Schierwagen, I., Verbeke, L., Hittatiya, K., Uschner, F. E., Manekeller, S., Strassburg, C. P., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309600 · Cited by 69
Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2)
Rowbottom, M. W., Bain, G., Calderon, I., Lasof, T., Lonergan, D. G., Lai, A. G., Huang, F., Darlington, J. V., Prodanovich, P., Santini, A. M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00345 · Cited by 69
The specialized proresolving lipid mediator maresin 1 protects hepatocytes from lipotoxic and hypoxia‐induced endoplasmic reticulum stress
Rius, B., Duran‐Güell, M., Flores‐Costa, R., López‐Vicario, C., Lopategi, A., Alcaraz‐Quiles, J., Casulleras, M., Lozano, J. J., Titos, E., & Clària, J. (2017) · The FASEB Journal · doi:10.1096/fj.201700394r · Cited by 69
Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism
Li, J., Ghazwani, M., Liu, K., Huang, Y., Chang, N., Fan, J., He, F., Li, L., Bu, S., Xie, W., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182679 · Cited by 69
Eosinophils and Macrophages within the Th2-Induced Granuloma: Balancing Killing and Healing in a Tight Space
Ariyaratne, A., & Finney, C. A. M. (2019) · Infection and Immunity · doi:10.1128/iai.00127-19 · Cited by 68
Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice
Xu, J., Ma, H., Liu, X., Rosenthal, S. B., Baglieri, J., McCubbin, R., Sun, M., Koyama, Y., Geoffroy, C. G., Saijo, K., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.131277 · Cited by 68
Self-citation
Key Players of Hepatic Fibrosis
Dawood, R. M., El-Meguid, M. A., Salum, G. M., & Awady, M. K. E. (2020) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2020.0059 · Cited by 68
Macrophage–stroma interactions in fibrosis: biochemical, biophysical, and cellular perspectives
Vasse, G. F., Nizamoglu, M., Heijink, I. H., Schlepütz, M., van Rijn, P., Thomas, M. J., Burgess, J. K., & Melgert, B. N. (2021) · The Journal of Pathology · doi:10.1002/path.5632 · Cited by 70
Recent advances in bioprinting technologies for engineering hepatic tissue
Agarwal, T., Banerjee, D., Konwarh, R., Esworthy, T. J., Kumari, J., Onesto, V., Das, P., Lee, B. H., Wagener, F. A. D. T. G., Makvandi, P., et al. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112013 · Cited by 68
Exosome-based therapies for inflammatory disorders: a review of recent advances
Saleem, M., Shahzad, K. A., Marryum, M., Singh, S., Zhou, Q., Du, S., Wang, S., Shao, C., & Shaikh, I. I. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04107-2 · Cited by 68
NLRP3 inflammasome in health and disease (Review)
Wang, H., Ma, L., Su, W., Liu, Y., Xie, N., & Liu, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5489 · Cited by 70
Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis
Li, C., Hsiang, C., Wu, S., & Ho, T. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.02.025 · Cited by 68
Cirrhosis and mortality risks of biopsy‐verified alcoholic pure steatosis and steatohepatitis: a nationwide registry‐based study
Deleuran, T., Grønbæk, H., Vilstrup, H., & Jepsen, P. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05091.x · Cited by 68
The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8
Clément, S., Pascarella, S., Conzelmann, S., Gonelle‐Gispert, C., Guilloux, K., & Negro, F. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.035 · Cited by 68
The Interplay between Inflammation and Fibrosis in Kidney Transplantation
Torres, I. B., Moreso, F., Sarró, E., Meseguer, A., & Serón, D. (2014) · BioMed Research International · doi:10.1155/2014/750602 · Cited by 68
Liver and spleen volume variations in patients with hepatic fibrosis
Liu, P., Li, P., Wen, H., & Zhao, L. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.3298 · Cited by 68
Quantification of Liver Viscoelasticity with Acoustic Radiation Force: A Study of Hepatic Fibrosis in a Rat Model
Chen, X., Shen, Y., Zheng, Y., Lin, H., Guo, Y., Zhu, Y., Zhang, X., Wang, T., & Chen, S. (2013) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2013.05.020 · Cited by 68
Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic Fibrosis
Tennakoon, A. H., Izawa, T., Kuwamura, M., & Yamate, J. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm5010004 · Cited by 68
Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease
Shoji, H., Yoshio, S., Mano, Y., Kumagai, E., Sugiyama, M., Korenaga, M., Arai, T., Itokawa, N., Atsukawa, M., Aikata, H., et al. (2016) · Scientific Reports · doi:10.1038/srep28814 · Cited by 68
Antifibrotic effects of crocin on thioacetamide-induced liver fibrosis in mice
Algandaby, M. M. (2016) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2016.10.007 · Cited by 68
Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells
Chen, Y., Fan, Y., Guo, D.-Y., Xu, B., Shi, X.-Y., Li, J.-T., & Duan, L.-F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110413 · Cited by 63
The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1
Xi, Y., Li, Y., Xu, P., Li, S., Liu, Z., Tung, H.-C., Cai, X., Wang, J., Huang, H., Wang, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg9241 · Cited by 67

Authors: Bataller, R., & Brenner, D. A.
Affiliations: Columbia University (US)
Corresponding author: Brenner, David A.
ORCID: Brenner, David A.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2005-02-01
Volume: 115
Issue: 2
Pages: 209-218
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci24282
OpenAlex: W4255712601
Cited by: 4,958
References: 134
Citations by year: 2026: 177 · 2025: 236 · 2024: 285 · 2023: 289 · 2022: 307 · 2021: 321 · 2020: 294 · 2019: 275 · 2018: 284 · 2017: 295 · 2016: 281 · 2015: 307 · 2014: 229 · 2013: 224 · 2012: 222
FWCI: 17.47
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed (publishedVersion)
Funders: Ministerio de Ciencia y Tecnología
National Institutes of Health
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords: liver fibrosis, extracellular matrix accumulation, collagen deposition, chronic liver disease, liver cirrhosis, hepatic stellate cells, portal fibroblasts, myofibroblasts, TGF-β1, angiotensin II, leptin, fibrogenic cytokines, antifibrotic agents, fibrosis pathogenesis, fibrosis diagnosis, liver transplantation
MeSH terms: Angiotensin II, Animals, Humans, Hypertension, Portal, Liver Cirrhosis, Transforming Growth Factor beta, Liver Failure, Leptin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Liver fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks